tiprankstipranks
Trending News
More News >

Sorrento Therapeutics price target lowered to $13 from $20 at H.C. Wainwright

H.C. Wainwright analyst Raghuram Selvaraju lowered the firm’s price target on Sorrento Therapeutics to $13 from $20 and keeps a Buy rating on the shares. The reduced target accounts for the continuing evolution of the COVID-19 pandemic, the analyst tells investors in a research note.

Don’t Miss TipRanks’ Half-Year Sale

Published first on TheFly

See Insiders’ Hot Stocks on TipRanks >>

Read More on SRNE:

Disclaimer & DisclosureReport an Issue

1